Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Merkel Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Looking for participantsNCT07749586
What this trial is testing

Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Arvinas Inc. 499
Testing effectiveness (Phase 2)UnknownNCT03544723
What this trial is testing

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Who this might be right for
Solid TumorLymphoma
MultiVir, Inc. 40
Testing effectiveness (Phase 2)WithdrawnNCT04276597
What this trial is testing

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.

Who this might be right for
Pulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more
Excel Diagnostics and Nuclear Oncology Center
Testing effectiveness (Phase 2)Looking for participantsNCT07288073
What this trial is testing

TIL Therapy in cSCC and MCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaMerkel Cell CarcinomaMetastatic Cutaneous Squamous Cell Carcinoma+1 more
Karam Khaddour, MD, MS 14
Testing effectiveness (Phase 2)Ended earlyNCT03435640
What this trial is testing

REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies

Who this might be right for
MelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more
Nektar Therapeutics 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Not applicableNot Yet RecruitingNCT06039033
What this trial is testing

Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns

Who this might be right for
Merkel Cell Carcinoma
Power Life Sciences Inc. 500
Early research (Phase 1)Ended earlyNCT04596033
What this trial is testing

TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck+6 more
Genocea Biosciences, Inc. 49
Testing effectiveness (Phase 2)Ended earlyNCT04725331
What this trial is testing

A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors

Who this might be right for
Metastatic CancerSoft Tissue SarcomaMerkel Cell Carcinoma+3 more
Transgene 31
Not applicableLooking for participantsNCT06753136
What this trial is testing

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Who this might be right for
Primary Visceral Tumors of Any HistotypeVisceral LesionsLiver Cancer+9 more
Istituto Oncologico Veneto IRCCS 24
Early research (Phase 1)Active Not RecruitingNCT04047251
What this trial is testing

FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma

Who this might be right for
Advanced Solid TumorsMerkel Cell Carcinoma
Fujifilm Pharmaceuticals U.S.A., Inc. 96
Early research (Phase 1)Study completedNCT00346385
What this trial is testing

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Ovarian CancerMerkel Cell CarcinomaSCLC
ImmunoGen, Inc. 97
Early research (Phase 1)Ended earlyNCT05069935
What this trial is testing

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 16
Not applicableLooking for participantsNCT02471352
What this trial is testing

Studies of Dermatologic Diseases Biospecimen Acquisition Protocol

Who this might be right for
Dermatologic ConditionsHealthy VolunteersNormal Volunteers+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 700
Early research (Phase 1)Study completedNCT01652547
What this trial is testing

A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma

Who this might be right for
Metastatic Melanoma and Merkel Cell Carcinoma
Novartis Pharmaceuticals 10
Testing effectiveness (Phase 2)Ended earlyNCT04590781
What this trial is testing

Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer

Who this might be right for
Merkel Cell CarcinomaSmall Cell Lung Cancer
Xencor, Inc. 4
Early research (Phase 1)Study completedNCT03071757
What this trial is testing

The Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 139
Testing effectiveness (Phase 2)Study completedNCT01013779
What this trial is testing

Merkel Positron Emission Tomography (PET) Protocol

Who this might be right for
Merkel Cell Carcinoma
Trans Tasman Radiation Oncology Group 43
Early research (Phase 1)Looking for participantsNCT07006727
What this trial is testing

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaLarge Cell Neuroendocrine Carcinoma of the LungNeuroendocrine Prostate Cancer+8 more
Novartis Pharmaceuticals 116
Next Page